Lorisk Depot 11.25 mg Combikit Injection 1's Substitute
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
LEUPRORELIN-11.25MG
Uses:
Treatment of Prostate cancer, Breast cancer, Endometriosis, Premature puberty
Medicinal Benefits:
Lorisk Depot 11.25 mg Combikit Injection 1's contains Leuprorelin which works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and oestrogen in women. Thereby, Lorisk Depot 11.25 mg Combikit Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of the tumour or causing it to shrink. Also, Lorisk Depot 11.25 mg Combikit Injection 1's is used to treat hormone-responsive breast cancer in pre and postmenopausal women. By reducing testosterone and oestrogen levels, Lorisk Depot 11.25 mg Combikit Injection 1's delays the onset of puberty in children.
Lorisk Depot 11.25 mg Combikit Injection 1's contains Leuprorelin, a synthetic hormone that works similar to the natural hormone, gonadotropin-releasing hormone (GnRH) by acting on the pituitary gland and decreases the levels of testosterone in men and oestrogen in women. Thereby, Lorisk Depot 11.25 mg Combikit Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of tumour or causing it to shrink.
Lorisk Depot 11.25 mg Combikit Injection 1's may stop menstrual periods. However, after 7 to 12 weeks of taking the final dose of injection, periods will resume. Please consult a doctor if you have any concerns regarding this.
Lorisk Depot 11.25 mg Combikit Injection 1's should be used with caution in diabetic patients as it may increase the risk of high blood sugar levels. Therefore, it is advised to regularly monitor blood sugar levels while taking Lorisk Depot 11.25 mg Combikit Injection 1's and inform your doctor if you have diabetes before taking Lorisk Depot 11.25 mg Combikit Injection 1's.
Lorisk Depot 11.25 mg Combikit Injection 1's may be used to treat endometriosis (tissue lining the uterus known as endometrium grows outside the uterus). Lorisk Depot 11.25 mg Combikit Injection 1's reduces oestrogen levels and causes menopause temporarily. Thereby, shrink the tissue outside the uterus or stop its growth.
Lorisk Depot 11.25 mg Combikit Injection 1's may decrease bone density, especially when used for the treatment of premature puberty in children. Therefore, regular monitoring of bone density is recommended while taking Lorisk Depot 11.25 mg Combikit Injection 1's.
Lorisk Depot 11.25 mg Combikit Injection 1's should be used with extreme caution in patients suffering from depression as it may worsen the condition. Therefore, inform your doctor if you have any history of depression before taking Lorisk Depot 11.25 mg Combikit Injection 1's.
No, Lorisk Depot 11.25 mg Combikit Injection 1's is not a chemotherapy medicine. It is a synthetic hormone which belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists.
Yes, Lorisk Depot 11.25 mg Combikit Injection 1's is a hormonal medicine that works by altering reproductive hormones. It is not recommended for use during pregnancy as it can harm the fetus and may lead to abortion. If you are pregnant or planning to become pregnant, please inform your doctor.
The common side effects of Lorisk Depot 11.25 mg Combikit Injection 1's are pain, redness, swelling, or skin hardening at the injection site, muscle weakness, bone pain, inability to have an erection, breast tenderness, headache, vaginal dryness, changes in breast size, acne, or mood swings. If any of these side effects persist or worsen, please consult your doctor.
Lorisk Depot 11.25 mg Combikit Injection 1's belongs to the class of synthetic hormones used in the treatment of prostate cancer in men, endometriosis, and hormone-responsive breast cancer in women. Also, it is used to treat premature puberty in children.